COFAMOX 20 POUDRE POUR SOLUTION BUVABLE
COFAMOX 20 POUDRE POUR SOLUTION BUVABLE
Authorised
- Amoxicillin trihydrate
Product identification
Medicine name:
COFAMOX 20 POUDRE POUR SOLUTION BUVABLE
Active substance:
- Amoxicillin trihydrate
Target species:
-
Chicken (broiler)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amoxicillin trihydrate230.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Chicken (broiler)
-
Meat and offal8dayLe temps d'attente est calculé à partir de la dernière administration du médicament.
Il est rappelé que quel que soit le temps d'attente, aucune denrée d'origine animale ne peut être livrée à la consommation humaine pendant toute la durée du traitement. -
Eggsno withdrawal periodEn l'absence d'un temps d'attente pour les œufs, ne pas utiliser chez les oiseaux pondeurs d’œufs ou destinés à la ponte d’œufs pour la consommation humaine (4 semaines avant le démarrage de la ponte et pendant celle-ci).
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Dopharma France
Marketing authorisation date:
Manufacturing sites for batch release:
- Dopharma France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4315169 3/2001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/04/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/04/2025
